Journal article · 2026

Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis

Gerald Francis Watts, Christie Mitchell Ballantyne, Agustín Blanco Echevarría, Jamie Smith, Robert S. Rosenson, Savitha Subramanian, James A. Trippi, Norman E. Lepor, Archna Bajaj, Vladimir Blaha, Russell S. Scott, Alexis Wilfrid Baass and 10 more

New England Journal of Medicine, 395(18), 1805–1817 · Published 4 November 2026 · DOI 10.1056/nejmoa2610014

View at the publisherCite this paper

In brief

“Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis” is a 2026 journal article by Gerald Francis Watts and 21 co-authors, published in New England Journal of Medicine. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
3.47
References
41
Authors
22

Abstract

BACKGROUND: messenger RNA, lowers triglyceride levels and potentially mitigates the risk of acute pancreatitis. METHODS: In two double-blind, placebo-controlled trials, 757 adults with severe hypertriglyceridemia were randomly assigned in a 2:1 ratio to receive plozasiran (25 mg) or placebo at baseline and at months 3, 6, and 9. These trials had identical designs, end points… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Watts, G. F., Ballantyne, C. M., Echevarría, A. B., Smith, J., Rosenson, R. S., Subramanian, S., Trippi, J. A., Lepor, N. E., Bajaj, A., Blaha, V., Scott, R. S., Baass, A. W., Goldberg, I. J., Gallo, A., Diaz, J. L., Saxena, M., Li, J., Zhou, R., Aiyer, L. P., . . . Gaudet, D. (2026). Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis. New England Journal of Medicine, 395(18), 1805–1817. https://doi.org/10.1056/nejmoa2610014

MLA 9

Watts, Gerald Francis, et al. “Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis.” New England Journal of Medicine, vol. 395, no. 18, 2026, pp. 1805–1817. https://doi.org/10.1056/nejmoa2610014.

Chicago

Watts, Gerald Francis, Christie Mitchell Ballantyne, Agustín Blanco Echevarría, Jamie Smith, Robert S. Rosenson, Savitha Subramanian, James A. Trippi, et al. 2026. “Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis.” New England Journal of Medicine 395 (18): 1805–1817. https://doi.org/10.1056/nejmoa2610014.

Harvard

Watts, G. F. et al. (2026) ‘Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis’, New England Journal of Medicine, 395(18), pp. 1805–1817. doi:10.1056/nejmoa2610014.

IEEE

G. F. Watts et al., “Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis,” New England Journal of Medicine, vol. 395, no. 18, pp. 1805–1817, 2026, doi: 10.1056/nejmoa2610014.

BibTeX

@article{watts2026plozasiran,
  title     = {{Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis}},
  author    = {Watts, Gerald Francis and Ballantyne, Christie Mitchell and Echevarría, Agustín Blanco and Smith, Jamie and Rosenson, Robert S. and Subramanian, Savitha and Trippi, James A. and Lepor, Norman E. and Bajaj, Archna and Blaha, Vladimir and Scott, Russell S. and Baass, Alexis Wilfrid and Goldberg, Ira J. and Gallo, Antonio and Diaz, Jose Luis and Saxena, Manish and Li, Jianping and Zhou, Rong and Aiyer, Lalitha Padmanabhan and Hellawell, Jennifer L. and Hamilton, James and Gaudet, Daniel},
  journal   = {New England Journal of Medicine},
  year      = {2026},
  volume    = {395},
  number    = {18},
  pages     = {1805--1817},
  doi       = {10.1056/nejmoa2610014},
  url       = {https://doi.org/10.1056/nejmoa2610014}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders

  • plozasiran
  • severe hypertriglyceridemia
  • acute pancreatitis
  • triglyceride lowering
  • remnant cholesterol
  • non-HDL cholesterol
  • RNA interference therapy
  • fasting plasma triglycerides

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Watts, G. F., Ballantyne, C. M., Echevarría, A. B., Smith, J., Rosenson, R. S., Subramanian, S., Trippi, J. A., Lepor, N. E., Bajaj, A., Blaha, V., Scott, R. S., Baass, A. W., Goldberg, I. J., Gallo, A., Diaz, J. L., Saxena, M., Li, J., Zhou, R., Aiyer, L. P., . . . Gaudet, D. (2026). Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis. New England Journal of Medicine, 395(18), 1805–1817. https://doi.org/10.1056/nejmoa2610014

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Gerald Francis Watts, Christie Mitchell Ballantyne, Agustín Blanco Echevarría, Jamie Smith, Robert S. Rosenson, Savitha Subramanian, James A. Trippi, Norman E. Lepor, Archna Bajaj, Vladimir Blaha, Russell S. Scott, Alexis Wilfrid Baass and 10 more.

What is the DOI of this paper?

10.1056/nejmoa2610014, permanently at https://doi.org/10.1056/nejmoa2610014. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.